D
Dimitrios P. Kontoyiannis
Researcher at University of Texas MD Anderson Cancer Center
Publications - 612
Citations - 32185
Dimitrios P. Kontoyiannis is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Aspergillosis & Cancer. The author has an hindex of 94, co-authored 578 publications receiving 27374 citations. Previous affiliations of Dimitrios P. Kontoyiannis include University of Texas Health Science Center at Houston & University of Houston.
Papers
More filters
Journal ArticleDOI
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly,Sharon C.-A. Chen,Carol A. Kauffman,William J. Steinbach,John W. Baddley,Paul E. Verweij,Cornelius J. Clancy,John R. Wingard,Shawn R. Lockhart,Andreas H. Groll,Tania C. Sorrell,Matteo Bassetti,Hamdi Akan,Barbara D. Alexander,David R. Andes,Elie Azoulay,Ralf Bialek,Robert W. Bradsher,Stéphane Bretagne,Thierry Calandra,Angela M. Caliendo,Elio Castagnola,Mario Cruciani,Manuel Cuenca-Estrella,Catherine F. Decker,Sujal R. Desai,Brian T. Fisher,Thomas S. Harrison,Claus Peter Heussel,Henrik Jeldtoft Jensen,Christopher C. Kibbler,Dimitrios P. Kontoyiannis,Bart Jan Kullberg,Katrien Lagrou,Frédéric Lamoth,Thomas Lehrnbecher,J. Loeffler,Olivier Lortholary,Johan Maertens,O. Marchetti,Kieren A. Marr,Henry Masur,Jacques F. Meis,C. Orla Morrisey,Marcio Nucci,Luis Ostrosky-Zeichner,Livio Pagano,Thomas F. Patterson,John R. Perfect,Zdenek Racil,Emmanuel Roilides,Marcus Ruhnke,Cornelia Schaefer Prokop,Shmuel Shoham,Monica A. Slavin,David A. Stevens,George Richard Thompson,Jose A. Vazquez,Claudio Viscoli,Thomas J. Walsh,Adilia Warris,L. Joseph Wheat,P. Lewis White,Theoklis E. Zaoutis,Peter G. Pappas +64 more
TL;DR: These updated definitions of IFDs should prove applicable in clinical, diagnostic, and epidemiologic research of a broader range of patients at high-risk.
Journal ArticleDOI
Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial
Johan Maertens,Issam I Raad,Kieren A. Marr,Thomas F. Patterson,Dimitrios P. Kontoyiannis,Oliver A. Cornely,Eric J. Bow,Galia Rahav,Dionysios Neofytos,Mickael Aoun,John W. Baddley,Michael Giladi,Werner J. Heinz,Raoul Herbrecht,William W. Hope,Meinolf Karthaus,Dong-Gun Lee,Olivier Lortholary,Vicki A. Morrison,Ilana Oren,Dominik Selleslag,Shmuel Shoham,George Richard Thompson,Misun Lee,Rochelle Maher,Anne Schmitt-Hoffmann,Bernhardt Zeiher,Andrew J. Ullmann +27 more
TL;DR: The results support the use of isavuconazole for the primary treatment of patients with invasive mould disease and non-inferiority was shown.
Journal ArticleDOI
Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria
Brahm H. Segal,Raoul Herbrecht,David A. Stevens,David A. Stevens,Luis Ostrosky-Zeichner,Jack D. Sobel,Claudio Viscoli,Thomas J. Walsh,Johan Maertens,Thomas F. Patterson,John R. Perfect,Bertrand Dupont,John R. Wingard,Thierry Calandra,Carol A. Kauffman,John R. Graybill,Lindsey R. Baden,Peter G. Pappas,John E. Bennett,Dimitrios P. Kontoyiannis,Catherine Cordonnier,Maria Anna Viviani,Jacques Bille,Nikolaos G. Almyroudis,L. Joseph Wheat,Wolfgang Graninger,Eric J. Bow,Steven M. Holland,Bart Jan Kullberg,William E. Dismukes,Ben E. De Pauw +30 more
TL;DR: An expert international panel consisting of the Mycoses Study Group and the European Organization for Research and Treatment of Cancer was convened to propose guidelines for assessing treatment responses in clinical trials of IFDs and for defining study outcomes.
Journal ArticleDOI
T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial
Eleftherios Mylonakis,Cornelius J. Clancy,Luis Ostrosky-Zeichner,Kevin W. Garey,George Alangaden,Jose A. Vazquez,Jeffrey S. Groeger,Marc A. Judson,Yuka Marie Vinagre,Stephen O. Heard,Fainareti N. Zervou,Ioannis M. Zacharioudakis,Dimitrios P. Kontoyiannis,Peter G. Pappas +13 more
TL;DR: T2MR is the first fully automated technology that directly analyzes whole blood specimens to identify species without the need for prior isolation of Candida species, and represents a breakthrough shift into a new era of molecular diagnostics.
Journal ArticleDOI
Mucormycosis Caused by Unusual Mucormycetes, Non-Rhizopus, -Mucor, and -Lichtheimia Species
Marisa Z. R. Gomes,Marisa Z. R. Gomes,Russell E. Lewis,Russell E. Lewis,Dimitrios P. Kontoyiannis +4 more
TL;DR: An overview of the epidemiology, clinical manifestations, diagnosis of, treatment of, and prognosis for unusual Mucormycetes infections (non-Rhizopus, -Mucor, and -Lichtheimia species) is provided.